bit.bio Raises $25 Million In Series D Funding As Human Cell Model Demand Surges 76%
· pulse2.com · popularity 17/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at pulse2.com →
Summary
bit.bio, a Cambridge, UK-based biotechnology company specializing in human cell programming, has raised $25 million in Series D funding to expand its portfolio of human cell models and meet growing demand from pharmaceutical companies, biotechnology businesses, and research organizations. The financing follows the company's Series C round earlier in 2026 and includes investments from existing backer M&G Investments and Dr. Jonathan Milner, founder and former CEO of Abcam. The post bit.bio Raises $25 Million In Series D Funding As Human Cell Model Demand Surges 76% appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 14.